Cargando…
Estrogen receptor testing and 10-year mortality from breast cancer: A model for determining testing strategy
BACKGROUND: The use of adjuvant tamoxifen therapy in the treatment of estrogen receptor (ER) expressing breast carcinomas represents a major advance in personalized cancer treatment. Because there is no benefit (and indeed there is increased morbidity and mortality) associated with the use of tamoxi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352613/ https://www.ncbi.nlm.nih.gov/pubmed/22616031 http://dx.doi.org/10.4103/2153-3539.95452 |